OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial
Maria Isabel Fernandes Lopes, Letícia Pastorelli Bonjorno, Marcela C Giannini, et al.
RMD Open (2021) Vol. 7, Iss. 1, pp. e001455-e001455
Open Access | Times Cited: 229
Maria Isabel Fernandes Lopes, Letícia Pastorelli Bonjorno, Marcela C Giannini, et al.
RMD Open (2021) Vol. 7, Iss. 1, pp. e001455-e001455
Open Access | Times Cited: 229
Showing 26-50 of 229 citing articles:
Gout, Rheumatoid Arthritis, and the Risk of Death Related to Coronavirus Disease 2019: An Analysis of the UK Biobank
Ruth Topless, Amanda Phipps‐Green, Megan Leask, et al.
ACR Open Rheumatology (2021) Vol. 3, Iss. 5, pp. 333-340
Open Access | Times Cited: 48
Ruth Topless, Amanda Phipps‐Green, Megan Leask, et al.
ACR Open Rheumatology (2021) Vol. 3, Iss. 5, pp. 333-340
Open Access | Times Cited: 48
Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19
Azita H. Talasaz, Parham Sadeghipour, Maryam Aghakouchakzadeh, et al.
Journal of the American College of Cardiology (2021) Vol. 78, Iss. 16, pp. 1635-1654
Open Access | Times Cited: 45
Azita H. Talasaz, Parham Sadeghipour, Maryam Aghakouchakzadeh, et al.
Journal of the American College of Cardiology (2021) Vol. 78, Iss. 16, pp. 1635-1654
Open Access | Times Cited: 45
Interventions for treatment of COVID-19: Second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project)
Sophie Juul, Emil Eik Nielsen, Joshua Feinberg, et al.
PLoS ONE (2021) Vol. 16, Iss. 3, pp. e0248132-e0248132
Open Access | Times Cited: 44
Sophie Juul, Emil Eik Nielsen, Joshua Feinberg, et al.
PLoS ONE (2021) Vol. 16, Iss. 3, pp. e0248132-e0248132
Open Access | Times Cited: 44
Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Peter Horby, Mark Campbell, Enti Spata, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 41
Peter Horby, Mark Campbell, Enti Spata, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 41
Impact of colchicine on mortality in patients with COVID-19: A meta-analysis
Dimitrios A. Vrachatis, Γεώργιος Γιαννόπουλος, Sotiria G. Giotaki, et al.
Hellenic Journal of Cardiology (2021) Vol. 62, Iss. 5, pp. 374-377
Open Access | Times Cited: 40
Dimitrios A. Vrachatis, Γεώργιος Γιαννόπουλος, Sotiria G. Giotaki, et al.
Hellenic Journal of Cardiology (2021) Vol. 62, Iss. 5, pp. 374-377
Open Access | Times Cited: 40
Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial
Jienchi Dorward, Ly‐Mee Yu, Gail Hayward, et al.
British Journal of General Practice (2022) Vol. 72, Iss. 720, pp. e446-e455
Open Access | Times Cited: 32
Jienchi Dorward, Ly‐Mee Yu, Gail Hayward, et al.
British Journal of General Practice (2022) Vol. 72, Iss. 720, pp. e446-e455
Open Access | Times Cited: 32
Advancing combination treatment with glycyrrhizin and boswellic acids for hospitalized patients with moderate COVID-19 infection: a randomized clinical trial
Adel A. Gomaa, Hamdy Saad Mohamed, Rasha B. Abd-ellatief, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 2, pp. 477-486
Open Access | Times Cited: 29
Adel A. Gomaa, Hamdy Saad Mohamed, Rasha B. Abd-ellatief, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 2, pp. 477-486
Open Access | Times Cited: 29
Inflammasomes and IL-1 family cytokines in SARS-CoV-2 infection: from prognostic marker to therapeutic agent
Jozefien Declercq, Elisabeth De Leeuw, Bart N. Lambrecht
Cytokine (2022) Vol. 157, pp. 155934-155934
Open Access | Times Cited: 29
Jozefien Declercq, Elisabeth De Leeuw, Bart N. Lambrecht
Cytokine (2022) Vol. 157, pp. 155934-155934
Open Access | Times Cited: 29
NLRP3, the inflammasome and COVID-19 infection
Maureen Yin, Laura Marrone, Christian G. Peace, et al.
QJM (2023) Vol. 116, Iss. 7, pp. 502-507
Open Access | Times Cited: 16
Maureen Yin, Laura Marrone, Christian G. Peace, et al.
QJM (2023) Vol. 116, Iss. 7, pp. 502-507
Open Access | Times Cited: 16
Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies
Elisa Souza Vaz, Sandra V. Vassiliades, Jeanine Giarolla, et al.
European Journal of Clinical Pharmacology (2023) Vol. 79, Iss. 6, pp. 723-751
Open Access | Times Cited: 16
Elisa Souza Vaz, Sandra V. Vassiliades, Jeanine Giarolla, et al.
European Journal of Clinical Pharmacology (2023) Vol. 79, Iss. 6, pp. 723-751
Open Access | Times Cited: 16
The role of colchicine in the management of COVID-19: a Meta-analysis
Kholoud Elshiwy, Ghada Essam El-Din Amin, Mohamed Nazmy Farres, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Kholoud Elshiwy, Ghada Essam El-Din Amin, Mohamed Nazmy Farres, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Effect of increasing doses of colchicine on the treatment of 333 COVID‐19 inpatients
Rumen Tiholov, A Lilov, Gergana Georgieva, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 5
Open Access | Times Cited: 5
Rumen Tiholov, A Lilov, Gergana Georgieva, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 5
Open Access | Times Cited: 5
NLRP3 Inflammasomes: Dual Function in Infectious Diseases
Yanbo Li, Rui Qiang, Zheng-Min Cao, et al.
The Journal of Immunology (2024) Vol. 213, Iss. 4, pp. 407-417
Closed Access | Times Cited: 5
Yanbo Li, Rui Qiang, Zheng-Min Cao, et al.
The Journal of Immunology (2024) Vol. 213, Iss. 4, pp. 407-417
Closed Access | Times Cited: 5
Alkaloids Derived from Tyrosine: Phenethylisoquinoline (Colchicine)
Mihir Halder, Pijush Paul, Sumita Jha
Springer eBooks (2025), pp. 1-36
Closed Access
Mihir Halder, Pijush Paul, Sumita Jha
Springer eBooks (2025), pp. 1-36
Closed Access
2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19
Alessia Alunno, Aurélie Najm, Pedro Machado, et al.
Annals of the Rheumatic Diseases (2021) Vol. 81, Iss. 1, pp. 34-40
Open Access | Times Cited: 37
Alessia Alunno, Aurélie Najm, Pedro Machado, et al.
Annals of the Rheumatic Diseases (2021) Vol. 81, Iss. 1, pp. 34-40
Open Access | Times Cited: 37
Darunavir ethanolate: Repurposing an anti-HIV drug in COVID-19 treatment
Vivek P. Chavda, Normi D. Gajjar, Nirav Shah, et al.
European Journal of Medicinal Chemistry Reports (2021) Vol. 3, pp. 100013-100013
Open Access | Times Cited: 37
Vivek P. Chavda, Normi D. Gajjar, Nirav Shah, et al.
European Journal of Medicinal Chemistry Reports (2021) Vol. 3, pp. 100013-100013
Open Access | Times Cited: 37
Effect of Colchicine vs Usual Care Alone on Intubation and 28-Day Mortality in Patients Hospitalized With COVID-19
Rafael Díaz, Andrés Orlandini, Noelia Castellana, et al.
JAMA Network Open (2021) Vol. 4, Iss. 12, pp. e2141328-e2141328
Open Access | Times Cited: 35
Rafael Díaz, Andrés Orlandini, Noelia Castellana, et al.
JAMA Network Open (2021) Vol. 4, Iss. 12, pp. e2141328-e2141328
Open Access | Times Cited: 35
Tocilizumab administration for the treatment of hospitalized patients with COVID ‐19: A systematic review and meta‐analysis
Christos Kyriakopoulos, Georgios Ntritsos, Athena Gogali, et al.
Respirology (2021) Vol. 26, Iss. 11, pp. 1027-1040
Open Access | Times Cited: 34
Christos Kyriakopoulos, Georgios Ntritsos, Athena Gogali, et al.
Respirology (2021) Vol. 26, Iss. 11, pp. 1027-1040
Open Access | Times Cited: 34
Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP)
Matteo Bassetti, Daniele Roberto Giacobbe, Paolo Bruzzi, et al.
Infectious Diseases and Therapy (2021) Vol. 10, Iss. 4, pp. 1837-1885
Open Access | Times Cited: 33
Matteo Bassetti, Daniele Roberto Giacobbe, Paolo Bruzzi, et al.
Infectious Diseases and Therapy (2021) Vol. 10, Iss. 4, pp. 1837-1885
Open Access | Times Cited: 33
Colchicine use in patients with COVID-19: A systematic review and meta-analysis
Leonard Chiu, Chun‐Han Lo, Max Shen, et al.
PLoS ONE (2021) Vol. 16, Iss. 12, pp. e0261358-e0261358
Open Access | Times Cited: 33
Leonard Chiu, Chun‐Han Lo, Max Shen, et al.
PLoS ONE (2021) Vol. 16, Iss. 12, pp. e0261358-e0261358
Open Access | Times Cited: 33
The effectiveness of Colchicine as an anti-inflammatory drug in the treatment of coronavirus disease 2019: Meta-analysis
Monireh Golpour, Tahoora Mousavi, Mina Alimohammadi, et al.
International Journal of Immunopathology and Pharmacology (2021) Vol. 35, pp. 205873842110317-205873842110317
Open Access | Times Cited: 32
Monireh Golpour, Tahoora Mousavi, Mina Alimohammadi, et al.
International Journal of Immunopathology and Pharmacology (2021) Vol. 35, pp. 205873842110317-205873842110317
Open Access | Times Cited: 32
Synthesis of Seleno-Dibenzocycloheptenones/Spiro[5.5]Trienones by Radical Cyclization of Biaryl Ynones
Helen A. Goulart, Ricardo H. Bartz, Thiago J. Peglow, et al.
The Journal of Organic Chemistry (2022) Vol. 87, Iss. 6, pp. 4273-4283
Closed Access | Times Cited: 26
Helen A. Goulart, Ricardo H. Bartz, Thiago J. Peglow, et al.
The Journal of Organic Chemistry (2022) Vol. 87, Iss. 6, pp. 4273-4283
Closed Access | Times Cited: 26
The Fragility of Statistically Significant Results in Randomized Clinical Trials for COVID-19
Takahiro Itaya, Yotsuha Isobe, Sayoko Suzuki, et al.
JAMA Network Open (2022) Vol. 5, Iss. 3, pp. e222973-e222973
Open Access | Times Cited: 22
Takahiro Itaya, Yotsuha Isobe, Sayoko Suzuki, et al.
JAMA Network Open (2022) Vol. 5, Iss. 3, pp. e222973-e222973
Open Access | Times Cited: 22
C5aR1 signaling triggers lung immunopathology in COVID-19 through neutrophil extracellular traps
Bruna M. Silva, Giovanni Freitas Gomes, Flávio P. Veras, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 12
Open Access | Times Cited: 15
Bruna M. Silva, Giovanni Freitas Gomes, Flávio P. Veras, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 12
Open Access | Times Cited: 15
Colchicine for the treatment of patients with COVID-19: an updated systematic review and meta-analysis of randomised controlled trials
Huzaifa Ahmad Cheema, Uzair Jafar, Abia Shahid, et al.
BMJ Open (2024) Vol. 14, Iss. 4, pp. e074373-e074373
Open Access | Times Cited: 4
Huzaifa Ahmad Cheema, Uzair Jafar, Abia Shahid, et al.
BMJ Open (2024) Vol. 14, Iss. 4, pp. e074373-e074373
Open Access | Times Cited: 4
